-
An Analysis of Possible Reference Countries for a US Most-Favored Nation Policy and the Associated Impact on the Global Pharmaceutical Industry
Sep 9, 2025, 16:22 PM -
Avacopan in the Treatment of ANCA-Associated Vasculitis: A Cost-Utility Analysis in Portugal
Sep 9, 2025, 16:22 PM -
Diverging Impacts of Evergreening and Biosimilars on Trastuzumab Utilization and Costs in South Korea: Implications for Sustainable Access and Market Competition
Sep 9, 2025, 16:22 PM -
Impact of County-Level Socioeconomic Vulnerability on Time to Treatment and Survival in Patients With Early Stage Colorectal Cancer
Sep 9, 2025, 16:22 PM -
Evaluating the Validity of Immunotherapy in Retreatment and Rechallenge Strategies for Oncology Patients
Sep 9, 2025, 16:22 PM -
Baseline Characteristics and Treatment Persistence in UK Patients With Moderate-to-Severe UC Following 12-Week Mirikizumab Induction: Real-World Data From IBD BioResource
Sep 9, 2025, 16:22 PM -
Operational and Economic Impact of CLL Treatment Regimens: Insights From a Multidisciplinary Study in Portugal
Sep 9, 2025, 16:22 PM -
Real-World Adherence to Nonhormonal Therapies for Menopause-Related Vasomotor Symptoms: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Assessment of the Inclusion and Importance of Carer Quality of Life in Global Health Technology Appraisals
Sep 9, 2025, 16:22 PM -
Sedative-Hypnotic Drug Use and Polypharmacy Patterns Associated With Risk of Falls and Fractures in Older Adults by Osteoporosis Status: A Korean Nationwide Senior Cohort Study
Sep 9, 2025, 16:22 PM -
Investigating Functional Status and Healthcare Resource Utilization of Patients With Cognitive Impairment Associated With Schizophrenia: Findings From a Real-World Noninterventional Study
Sep 9, 2025, 16:22 PM -
Effectiveness of Subcutaneous Natalizumab in Multiple Sclerosis: Real-World Evidence From a Finnish Registry Study
Sep 9, 2025, 16:22 PM -
Factors Affecting Pricing and Reimbursement for Pharmaceuticals in Southeast Asian Countries
Sep 9, 2025, 16:22 PM -
HTA and Regulatory Perspectives on Robustness of Evidence and Management of Uncertainties
Sep 9, 2025, 16:22 PM -
The Development of the Multicriteria Decision Analysis in Specialized Burn Care: The Methodological Process
Sep 9, 2025, 16:22 PM -
Feasibility Assessment of a Real-World Comparator Cohort Using Multiple Qualifying Index Lines of Therapy (LOTs) in Third-Line or Later (3L+) Diffuse Large B-cell Lymphoma (DLBCL)
Sep 9, 2025, 16:22 PM -
Beyond Productivity: How Professional Identity Shapes Generative AI Adoption Among Medical Writing Professionals
Sep 9, 2025, 16:22 PM -
The Inclusion of Qualitative Patient Experience Data in HTA and Reimbursement Dossiers: A Review of Templates From Eight HTA Bodies
Sep 9, 2025, 16:22 PM -
Comparison of Time-Driven Activity-Based Costs Incurred by Patients and Caregivers Related to Intravitreal Injections for Retinal Vein Occlusion
Sep 9, 2025, 16:22 PM -
Drivers of Improvement in Observed Survival in Malignant Cancer Sites: A Cancer Registry Analysis
Sep 9, 2025, 16:22 PM